Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039009 | SCV000062687 | benign | not specified | 2011-09-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000039009 | SCV000170605 | benign | not specified | 2014-01-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000247372 | SCV000317556 | benign | Cardiovascular phenotype | 2015-06-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000315825 | SCV000563520 | benign | Hypertrophic cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625401 | SCV000745242 | benign | Hypertrophic cardiomyopathy 16 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Leiden Muscular Dystrophy |
RCV000024479 | SCV000045783 | not provided | not provided | 2012-04-20 | no assertion provided | curation | |
Clinical Genetics, |
RCV000039009 | SCV001922122 | benign | not specified | no assertion criteria provided | clinical testing |